exemestane

Poland

Drugs containing this active substance

  • ASTEXANA

    Astexana is used to treat early-stage hormone-dependent breast cancer in postmenopausal women (after completion of 2-3 years of tamoxifen treatment) and to treat advanced-stage breast cancer in postmenopausal women who have not responded to other hormonal treatments.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane 25 mg

    ATC: L02BG06

    Manufacturer: EirGen Pharma Limited Vipharm S.A.

  • The medicine is used in the treatment of early-stage hormone-dependent breast cancer in postmenopausal women (who have completed 2-3 years of tamoxifen treatment) and in the treatment of advanced stages of this cancer in postmenopausal women for whom other hormonal therapies have not been effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane 25 mg

    ATC: L02BG06

    Manufacturer: Krka, d.d., Novo mesto

  • It is used for the treatment of early hormone-dependent breast cancer in postmenopausal women (after 2-3 years of treatment with tamoxifen) and for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed despite the use of other hormonal therapies.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane 25 mg

    ATC: L02BG06

    Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise

  • It is used in the treatment of early or advanced hormone-dependent breast cancer in postmenopausal women.

    Form: tablets, coated

    Active substance Dosage
    exemestane 25 mg

    ATC: L02BG06

    Manufacturer: Symphar Sp. z o.o.

  • The medicine is used to treat early or advanced hormone-dependent breast cancer in postmenopausal women.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane 25 mg

    ATC: L02BG06

    Manufacturer: Remedica Ltd